Comparison of the efficacy of different doses of omalizumab (150 mg vs 300 mg) in patients with seasonal allergic rhinitis and low total IgE: A randomized, double-blind, controlled study
- DOI
- 10.1016/j.waojou.2026.101394
- Published
- 2026-07
- Container
- World Allergy Organization Journal
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.waojou.2026.101394,
title = {Comparison of the efficacy of different doses of omalizumab (150 mg vs 300 mg) in patients with seasonal allergic rhinitis and low total IgE: A randomized, double-blind, controlled study},
author = {Lisha Li and Yingyang Xu and Sainan Bian and Zhouxian Pan and Kai Guan},
year = {2026},
journal = {World Allergy Organization Journal},
doi = {10.1016/j.waojou.2026.101394},
url = {https://doi.org/10.1016/j.waojou.2026.101394}
}RIS
TY - JOUR TI - Comparison of the efficacy of different doses of omalizumab (150 mg vs 300 mg) in patients with seasonal allergic rhinitis and low total IgE: A randomized, double-blind, controlled study AU - Lisha Li AU - Yingyang Xu AU - Sainan Bian AU - Zhouxian Pan AU - Kai Guan PY - 2026 JO - World Allergy Organization Journal DO - 10.1016/j.waojou.2026.101394 UR - https://doi.org/10.1016/j.waojou.2026.101394 ER -
APA
Li, L., Xu, Y., Bian, S., Pan, Z., & Guan, K. (2026). Comparison of the efficacy of different doses of omalizumab (150 mg vs 300 mg) in patients with seasonal allergic rhinitis and low total IgE: A randomized, double-blind, controlled study. World Allergy Organization Journal. https://doi.org/10.1016/j.waojou.2026.101394
Source records
- crossref · retrieved 2026-09-27T08:18:43.724Z